Geron: Funding, Investors & Team (Oct 2026)
Geron is a biotechnology firm known for its focus on creating treatments for blood cancers like hematologic malignancies. The company's Imetelstat, a groundbreaking telomerase inhibitor, utilizes award-winning research to potentially revolutionize the treatment of these diseases. Founded in 1990, Geron is based in Foster City, California.
Geron has raised $628M across 3 funding rounds on record, the most recent an undisclosed round of $250M announced in Nov 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Geron Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Geron Funding Rounds
Geron raised $228M in an undisclosed round announced in Jan 2023.
1.2 years later, an undisclosed round of $150M was announced in Mar 2024.
8 months later, an undisclosed round of $250M was announced in Nov 2024.
Geron Founders and Leadership Team
No contact details are on record for this team yet.
Geron Funding Compared to Other Biotechnology Startups
Geron's latest round of $250M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Geron in Biotechnology and Foster City
Companies Similar to Geron
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Geron Funding FAQs
What does Geron do?
Geron is a biotechnology firm known for its focus on creating treatments for blood cancers like hematologic malignancies. The company's Imetelstat, a groundbreaking telomerase inhibitor, utilizes award-winning research to potentially revolutionize the treatment of these diseases. Founded in 1990, Geron is based in Foster City, California.
How much funding has Geron raised?
Geron has raised $628M across 3 rounds on record. The most recent is an undisclosed round of $250M announced in Nov 2024.
When did Geron last raise funding?
Geron's most recent funding round on record is an undisclosed round of $250M, announced in Nov 2024.
Who founded Geron?
FundedIQ lists Chaim Geron (Founder), Emre Geron (Founder) at Geron.
Who is the CEO of Geron?
John Scarlett is listed as CEO at Geron.
Where is Geron headquartered?
Geron is based in Foster City, California, United States.
How many employees does Geron have?
Geron is in the 251-500 employee band.
How does Geron's funding compare to other Biotechnology startups?
Geron's latest round of $250M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Geron Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Geron is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.